Dimitri BEDO

Arteriovenous fistula for haemodialysis as a predictor of de novo heart failure in kidney transplant recipients doi.org/10.1093/ckj/sf…

#ACC25 #CircSimPub In a prespecified analysis of the SOUL trial, oral semaglutide reduced MACE outcomes independently of concomitant SGLT2i use in patients with T2DM and ASCVD and/or CKD. GLP1-RA and SGLT2i can be saf... ahajrnls.org/41RZkDd #AHAJournals @Dr_Birkenfeld @RBusui

Early and Sensitive Detection of #Cisplatin Induced #KidneyInjury Using Novel #Biomarkers #VisualAbstract by @jmteakell kireports.org/article/S2468-…

Le SNIN tient à vous souhaiter une belle et heureuse année 2025 🥳 On en profite pour vous présenter le bureau 2024/2025 ✨ (un peu tardivement, mais mieux vaut tard que jamais !!) Le meilleur reste à venir ! 🫡

Équipe très sympathique et compétente !!!

Now online in @NDTsocial Tissue fibrosis in cardiorenal syndrome: crosstalk between heart and kidneys 🧐 The repair process in cardiorenal injury involves a regenerative phase characterized by proliferation and polyploidization. ▶️academic.oup.com/ndt/article-ab…

@c_massoumipour @MaanaouiMehdi @amjtransplant @CR2TI_Nantes @CHUnantes @BranchereauJu @CantarovichD @SFTfrancophone Bravo !

Very proud to have our recent review about pancreas allograft immunothrombosis just published in @amjtransplant ! Huge team work with @CR2TI_Nantes @CHUnantes @BranchereauJu @CantarovichD and everybody from the @SFTfrancophone TREPID group !

LAURÉATS 2024] 🏅Félicitations à @RaphaelCarapito, lauréat du prix Éloi Collery pour ses travaux sur la #pathologie #alloimmunes et #autoimmunes/#inflammatoires @CHRUStrasbourg @inserm 🛜 bit.ly/3ZYIAZG

Un grand big-up et toutes mes félicitations au meilleur des nephrovirologues!

Type 2 myocardial infarction: challenges in diagnosis and treatment. Read this State-of-the-Art Review just published in #EHJ 👉 bit.ly/3VBGdd4 @RoccoMontone @ehj_ed

Atrial fibrillation (AF) is associated with increased rates of stroke, heart failure, and mortality. This narrative review examines the epidemiology, pathophysiology, diagnosis, and treatment of AF. ja.ma/3ZDdZ2D

🧐Selected from our joint @ERAkidney and @escardio Cardio-Kidney Collection: academic.oup.com/ndt/pages/join… ➡️Proximal versus distal diuretics in congestive heart failure 🔓doi.org/10.1093/ndt/gf…

The long-term effects of dapagliflozin in chronic kidney disease: a time-to-event analysis 🆓doi.org/10.1093/ndt/gf…

SGLT2 Inhibitor #SGLT2i in #Diabetic and #NonDiabetic Renal #Transplant Recipients #VisualAbstract by @DrPSVali kireports.org/article/S2468-…

Changing treatment paradigms for membranous nephropathies 🆓doi.org/10.1093/ndt/gf…

Risque bien de changer les pratiques !

Original Article: Edoxaban Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Artery Disease (EPIC-CAD) nej.md/3Z1D1d3 Editorial: Atrial Fibrillation and Stable Coronary Artery Disease nej.md/3T5MV9G #Cardiology

Intensive Blood-Pressure Control in Patients with Type 2 Diabetes: @NEJM 🥸 Day 3 of #AHA24 continues: Great work @AHAScience 😱 Let's summarize BPROAD trial 👇👇👇

Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity: @NEJM 🥸The SUMMIT trial - @AHAScience 😱 Summary 👇👇👇

In the CLEAR randomized trial involving patients with acute myocardial infarction, colchicine did not decrease the risk of major adverse cardiovascular events over a median follow-up period of 3 years. Full trial results: nej.md/4i2U6dV